Christopher Cai

Jan 9, 2025 | jamanetwork.com | Johns Hopkins |Victoria Bartlett |Michael Liu |Christopher Cai

Changes in Patient Care Experience After Private Equity Acquisition of US Hospitals A Policy Framework for the Growing Influence of Private Equity in Health Care Delivery Christopher Cai, MD; Zirui Song, MD, PhD Hospital Adverse Events and Patient Outcomes Associated With Private Equity Acquisition Sneha Kannan, MD; Joseph Dov Bruch, PhD; Zirui Song, MD, PhD Hospital Assets Before and After Private Equity Acquisition Elizabeth Schrier, MD; Hope E. M.

Sep 23, 2024 | jamanetwork.com | Christopher Cai |Aaron S. Kesselheim

In 2023, the Center for Medicare & Medicaid Innovation Center proposed the Medicare High-Value Drug List Model (hereafter, the model), in which Medicare Part D plans would voluntarily cap out-of-pocket costs at $2 per month for 150 high-value generic medications.1,2 We estimated potential savings from this policy.